Direct-to-Consumer (DTC) Genetic Testing Market Introduction and Overview
According to SPER Market Research, the Global Direct-to-Consumer (DTC) Genetic Testing Market is estimated to reach USD 5504.35 million by 2033 with a CAGR of 12.36%.
The report includes an in-depth analysis of the Global Direct-to-Consumer (DTC) Genetic Testing Market, including market size and trends, product mix, applications, and supplier analysis. Genetic tests are sold directly to consumers via a variety of marketing channels in direct-to-consumer (DTC) genetic testing. Customers buy a testing kit, take a DNA sample (usually with a cheek swab or saliva sample), and send it to a lab. The consumer receives direct results from the laboratory after the DNA analysis, frequently via an internet platform. Ancestry, genetic susceptibilities to certain diseases, carrier status for hereditary disorders, and a variety of individual characteristics like physical attributes or level of fitness can all be discovered through these tests. Without involving medical professionals, this direct access enables people to learn more about their genetic background and potential health concerns.
- MARCH 2021; 23andMe announced in March 2021 that it would merge with VG Acquisition Corp., a special purpose acquisition company (SPAC), in order to go public. The purpose of the merger was to increase the company's consumer health offerings and hasten its growth.
- FEBRUARY 2021; Leading genealogy and genetic testing company My Heritage unveiled My Heritage Health, a new offering, in February 2021. It gave users a thorough understanding of their genetic heritage and health risks by combining family history research with genetic testing.
Market Opportunities and Challenges
The market for DTC genetic testing is fuelled by a number of important factors. Demand for genetic insights that can guide lifestyle and medical decisions has increased due to growing consumer interest in personalized health and wellness. Thanks to technological advancements, genetic testing is now much more affordable and available to a wider range of people. Customers looking for quick and easy access to their genetic information are drawn to the ease of use of at-home testing kits and the convenience of online shopping. Increasing awareness and interest has also been greatly aided by marketing initiatives, especially those carried out online and on social media platforms. Among the many difficulties facing the DTC genetic testing market are questions regarding the dependability and accuracy of test results, which can differ amongst providers. Because genetic information about consumers may be misused or shared without authorization, privacy concerns are important. Without expert assistance, customers may also misinterpret the results, which could cause needless worry or misleading comfort. Inconsistent ethical and quality standards can also result from the industry's lack of regulation and standardization.
%20Genetic%20Testing%20Market%20%202-008481024052024.webp)
Market Competitive Landscape
The DTC genetic testing market is characterized by intense and ever-changing competition. Many businesses compete for market share by providing a variety of genetic testing services, such as health risk assessments and ancestry tracking. The major players in the market are Ancestry(US), 23andMe, Inc. (USA), Color Health, IncDante Labs, Inc., (US), EasyDNA(USA), Full Genomes Corporation, Inc.(US), Gene by Gene, Ltd.(US), Genesis HealthCare(US), Helix OpCo LLC(US), Living DNA Ltd (UK), others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Sales Channel, By Service, By Test type, By Technology, By End user
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Ancestry(US), 23andMe, Inc. (USA), Color Health, IncDante Labs, Inc., (US), EasyDNA(USA), Full Genomes Corporation, Inc.(US), Gene by Gene, Ltd.(US), Genesis HealthCare(US), Helix OpCo LLC(US), Living DNA Ltd (UK) Others |
COVID-19 Impact on Global Direct-to-Consumer (DTC) Genetic Testing Market
The DTC genetic testing market was affected by the COVID-19 pandemic in a variety of ways. On the one hand, processing and delivering test results were delayed due to supply chain disruptions and temporary lab closures. However, the pandemic's increased emphasis on wellness and health sparked consumer curiosity about hereditary susceptibilities to illnesses, including infection-related diseases. The popularity of at-home testing kits increased with the emergence of online and remote services, as consumers looked for easy ways to obtain health information without going to medical facilities.
Key Target Audience:
- Investors and Financial Analysts
- Healthcare Professionals
- Genetic Testing Companies
- Market Researchers
- Policy Makers and Regulators
- Consumer Advocacy Groups
- Technology and Innovation Specialists
Our in-depth analysis of the Direct-to-Consumer (DTC) Genetic Testing Market includes the following segments:
|
By Sales channels: |
Online Sales
OTC Sales
|
|
By Service: |
Diagnostic Screening
Prenatal
New-born Screening
Pre-Implantation Diagnosis
Relationship Testing
|
|
By Test Type: |
Carrier Testing
Predictive Testing
Ancestry
Relationship Testing
|
|
By Technology: |
Targeted Analysis
Single Nucleotide Polymorphism chips
Whole Genome Sequencing
|
|
By End User: |
Laboratories
Blood Banks
Nursing Homes
Hospitals
Home Care
|
Key Topics Covered in the Report:
- Global Direct-to-Consumer (DTC) Genetic Testing Market (FY’2024-FY’2033)
- Overview of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Sales Channel (Online Sales, OTC Sales and Doctor's Office)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing)
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS))
- Segmentation of Global Direct-to-Consumer (DTC) Genetic Testing Market By End User (Laboratories, Blood Banks, Nursing Home)
- Statistical Snap of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Expansion Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Problems and Obstacles in Global Direct-to-Consumer (DTC) Genetic Testing Market
- Competitive Landscape in the Global Direct-to-Consumer (DTC) Genetic Testing Market
- Impact of COVID-19 and Demonetization on Global Direct-to-Consumer (DTC) Genetic Testing Market
- Details on Current Investment in Global Direct-to-Consumer (DTC) Genetic Testing Market
- Competitive Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Prominent Players in the Global Direct-to-Consumer (DTC) Genetic Testing Market
- SWOT Analysis of Global Direct-to-Consumer (DTC) Genetic Testing Market
- Global Direct-to-Consumer (DTC) Genetic Testing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Direct-to-Consumer (DTC) Genetic Testing Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Surgical Drains Market
7. Global Surgical Drains Market, By Sales channels (USD Million) 2020-2033
7.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Sales Channel, 2020-2026
7.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Sales Channel, 2027-2033
7.3. Online Sales
7.4. OTC Sales
8. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (USD Million) 2020-2033
8.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Service, 2020-2026
8.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Service, 2027-2033
8.3. Diagnostic Screening
8.4. Prenatal
8.5. New-born Screening
8.6. Pre-Implantation Diagnosis
8.7. Relationship Testing
9. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Test Type (USD Million) 2020-2033
9.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Test Type, 2020-2026
9.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Test Type, 2027-2033
9.3. Carrier Testing
9.4. Predictive Testing
9.5. Ancestry
9.6. Relationship Testing
10. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Technology (USD Million) 2020-2033
10.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Technology, 2020-2026
10.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By Technology, 2027-2033
10.3. Targeted Analysis
10.4. Single Nucleotide Polymorphism chips
10.5. Whole Genome Sequencing
11. Global Direct-to-Consumer (DTC) Genetic Testing Market, By End User (USD Million) 2020-2033
11.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By End-User, 2020-2026
11.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Size, Share and Forecast, By End-User, 2027-2033
11.3. Laboratories
11.4. Blood Banks
11.5. Nursing Homes
11.6. Hospitals
11.7. Home Care
12. Global Direct-to-Consumer (DTC) Genetic Testing Market Forecast, 2020-2033 (USD Million)
12.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Size and Market Share
13. Global Direct-to-Consumer (DTC) Genetic Testing Market, By Region, 2020-2033 (USD Million)
13.1. Global Direct-to-Consumer (DTC) Genetic Testing Market Share By Region (2020-2026)
13.2. Global Direct-to-Consumer (DTC) Genetic Testing Market Share By Region (2027-2033)
13.3. Asia-Pacific
13.3.1. Australia
13.3.2. China
13.3.3. India
13.3.4. Japan
13.3.5. South Korea
13.3.6. Rest of Asia-Pacific
13.4. Europe
13.4.1. France
13.4.2. Germany
13.4.3. Italy
13.4.4. Spain
13.4.5. United Kingdom
13.4.6. Rest of Europe
13.5. Middle East and Africa
13.5.1. Kingdom of Saudi Arabia
13.5.2. United Arab Emirates
13.5.3. Qatar
13.5.4. South Africa
13.5.5. Egypt
13.5.6. Morocco
13.5.7. Nigeria
13.5.8. Rest of Middle-East and Africa
13.6. North America
13.6.1. Canada
13.6.2. Mexico
13.6.3. United States
13.7. Latin America
13.7.1. Argentina
13.7.2. Brazil
13.7.3. Rest of Latin America
14. Company Profile
14.1. Ancestry(US)
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. 23andMe, Inc. (USA)
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Color Health, Inc.(US)
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Dante Labs, Inc., (US)
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. EasyDNA(USA)
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Full Genomes Corporation, Inc.(US)
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Gene by Gene, Ltd.(US)
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Genesis HealthCare(US)
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Helix OpCo LLC(US)
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. Living DNA Ltd (UK)
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links